1. Home
  2. OPEN vs PTCT Comparison

OPEN vs PTCT Comparison

Compare OPEN & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

HOLD

Current Price

$4.71

Market Cap

4.7B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.44

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPEN
PTCT
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.5B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
OPEN
PTCT
Price
$4.71
$66.44
Analyst Decision
Sell
Buy
Analyst Count
3
16
Target Price
$1.67
$80.94
AVG Volume (30 Days)
34.3M
959.7K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
264.48
EPS
N/A
7.78
Revenue
$4,371,000,000.00
$264,734,000.00
Revenue This Year
$3.04
N/A
Revenue Next Year
$53.82
$19.30
P/E Ratio
N/A
$8.61
Revenue Growth
N/A
36.19
52 Week Low
$0.53
$35.95
52 Week High
$10.87
$87.50

Technical Indicators

Market Signals
Indicator
OPEN
PTCT
Relative Strength Index (RSI) 42.73 46.68
Support Level $4.26 $61.43
Resistance Level $4.97 $69.29
Average True Range (ATR) 0.30 2.35
MACD -0.02 0.35
Stochastic Oscillator 5.87 44.98

Price Performance

Historical Comparison
OPEN
PTCT

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: